Search Results
Does Luspatercept reduce blood transfusions in MDS patients?
Luspatercept reduces transfusion burden in MDS-related anemia: MEDALIST results
Results of MEDALIST: luspatercept reduces transfusion burden in MDS
Luspatercept Lowers the Transfusion Burden in Patients With Myelofibrosis-Associated Anemia
Luspatercept reduces need for blood transfusions in beta thalassemia and MDS
Luspatercept in RBC transfusion-dependent MF patients
New therapies for transfusion dependent MDS patients
Phase III MEDALIST Trial of Luspatercept for MDS
Luspatercept for MDS-associated anemia
Long-term results of BELIEVE: luspatercept in adults with transfusion-dependent beta-thalassemia
COMMANDS: luspatercept vs epoetin alfa for anemia in ESA-naive LR-MDS
BELIEVE: β-thalassemia treatment with luspatercept reduces transfusion burden
